$RCMT
RCM TECHNOLOGIES, INC.

2021 Q2 Form 10-Q Financial Statement

#000070084121000024 Filed on May 14, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q1
Revenue $44.55M $45.03M
YoY Change 36.44% -12.72%
Cost Of Revenue $33.70M $34.19M
YoY Change 39.55% -12.51%
Gross Profit $10.85M $10.84M
YoY Change 27.6% -13.37%
Gross Profit Margin 24.36% 24.08%
Selling, General & Admin $9.129M $10.24M
YoY Change 1.5% -2.19%
% of Gross Profit 84.14% 94.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $346.0K $335.0K
YoY Change 40.65% -15.62%
% of Gross Profit 3.19% 3.09%
Operating Expenses $9.475M $18.62M
YoY Change -2.02% 71.4%
Operating Profit $1.375M -$7.776M
YoY Change -217.82% -570.13%
Interest Expense $10.00K -$370.0K
YoY Change -105.0% -11.9%
% of Operating Profit 0.73%
Other Income/Expense, Net -$12.00K -$409.0K
YoY Change -94.85% -12.04%
Pretax Income $1.363M -$8.185M
YoY Change -197.36% -788.39%
Income Tax $400.0K -$2.240M
% Of Pretax Income 29.35%
Net Earnings $1.007M -$5.945M
YoY Change -201.51% -506.36%
Net Earnings / Revenue 2.26% -13.2%
Basic Earnings Per Share $0.09 -$0.45
Diluted Earnings Per Share $0.08 -$0.45
COMMON SHARES
Basic Shares Outstanding 11.54M 13.11M
Diluted Shares Outstanding 11.93M 13.11M

Balance Sheet

Concept 2021 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $700.0K $600.0K
YoY Change -56.25% -64.71%
Cash & Equivalents $678.0K $642.0K
Short-Term Investments
Other Short-Term Assets $4.200M $3.900M
YoY Change 82.61% 11.43%
Inventory
Prepaid Expenses
Receivables $45.28M $50.77M
Other Receivables $3.947M $1.891M
Total Short-Term Assets $54.11M $57.24M
YoY Change 23.97% -11.42%
LONG-TERM ASSETS
Property, Plant & Equipment $1.859M $2.493M
YoY Change -21.13% -23.78%
Goodwill $16.35M $16.35M
YoY Change 0.0% -6.72%
Intangibles $15.00K $336.0K
YoY Change -94.14% -49.17%
Long-Term Investments
YoY Change
Other Assets $3.200M $2.000M
YoY Change 23.08% 122.22%
Total Long-Term Assets $23.66M $26.71M
YoY Change -10.82% -5.24%
TOTAL ASSETS
Total Short-Term Assets $54.11M $57.24M
Total Long-Term Assets $23.66M $26.71M
Total Assets $77.77M $83.95M
YoY Change 10.82% -9.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.90M $8.500M
YoY Change 25.26% -9.57%
Accrued Expenses $14.80M $8.500M
YoY Change 39.62% -15.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $32.80M
YoY Change
Long-Term Debt Due $200.0K $300.0K
YoY Change -33.33% 0.0%
Total Short-Term Liabilities $27.76M $50.58M
YoY Change 31.25% 137.94%
LONG-TERM LIABILITIES
Long-Term Debt $22.10M $100.0K
YoY Change 12.76% -99.71%
Other Long-Term Liabilities $4.600M $6.400M
YoY Change -16.36% -12.33%
Total Long-Term Liabilities $26.70M $6.500M
YoY Change 6.37% -84.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.76M $50.58M
Total Long-Term Liabilities $26.70M $6.500M
Total Liabilities $54.84M $57.42M
YoY Change 17.59% -9.91%
SHAREHOLDERS EQUITY
Retained Earnings -$66.97M -$65.05M
YoY Change 1.4% 5.43%
Common Stock $826.0K $797.0K
YoY Change 3.25% 1.66%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.13M $14.99M
YoY Change 5.29% 0.0%
Treasury Stock Shares $5.025M $2.823M
Shareholders Equity $22.93M $26.54M
YoY Change
Total Liabilities & Shareholders Equity $77.77M $83.95M
YoY Change 10.82% -9.55%

Cashflow Statement

Concept 2021 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $1.007M -$5.945M
YoY Change -201.51% -506.36%
Depreciation, Depletion And Amortization $346.0K $335.0K
YoY Change 40.65% -15.62%
Cash From Operating Activities -$9.112M $929.0K
YoY Change -154.08% -116.72%
INVESTING ACTIVITIES
Capital Expenditures $47.00K $35.00K
YoY Change -142.73% -65.35%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$47.00K -$35.00K
YoY Change -32.86% -65.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $911.0K $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $9.215M -1.934M
YoY Change -158.21% -128.1%
NET CHANGE
Cash From Operating Activities -$9.112M 929.0K
Cash From Investing Activities -$47.00K -35.00K
Cash From Financing Activities $9.215M -1.934M
Net Change In Cash -$56.00K -1.205M
YoY Change -105.89% -198.29%
FREE CASH FLOW
Cash From Operating Activities -$9.112M $929.0K
Capital Expenditures $47.00K $35.00K
Free Cash Flow -$9.159M $894.0K
YoY Change -154.0% -115.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 rcmt Finance Lease Lessee Property Net
FinanceLeaseLesseePropertyNet
394000
CY2021Q2 rcmt Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
CY2021Q2 rcmt Future Grants Of Options Or Shares
FutureGrantsOfOptionsOrShares
209180
CY2021Q2 rcmt Finance Lease Cost
FinanceLeaseCost
93000
CY2020Q1 rcmt Finance Lease Cost
FinanceLeaseCost
80000
CY2021Q2 rcmt Finance Lease Lessee Accumulated Depreciation Of Property
FinanceLeaseLesseeAccumulatedDepreciationOfProperty
837000
CY2021Q1 rcmt Finance Lease Lessee Accumulated Depreciation Of Property
FinanceLeaseLesseeAccumulatedDepreciationOfProperty
746000
CY2021Q2 rcmt Finance Lease Lessee Property Net
FinanceLeaseLesseePropertyNet
303000
CY2020Q2 rcmt Annual Depreciation Rate
AnnualDepreciationRate
0.2
CY2021Q2 rcmt Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
21803000
CY2021Q1 rcmt Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
22327000
CY2021Q2 rcmt Capital Expenditures
CapitalExpenditures
47000
CY2020Q1 rcmt Capital Expenditures
CapitalExpenditures
35000
CY2021Q2 rcmt Equity Awards Issued
EquityAwardsIssued
380000
CY2020Q1 rcmt Equity Awards Issued
EquityAwardsIssued
172000
CY2021Q2 rcmt Estimated Future Contingent Consideration Payments
EstimatedFutureContingentConsiderationPayments
2884000
CY2021Q2 rcmt Estimated Future Contingent Consideration Payments Remainder Of Fiscal Year
EstimatedFutureContingentConsiderationPaymentsRemainderOfFiscalYear
520000
CY2021Q2 rcmt Estimated Future Contingent Consideration Payments Year Two
EstimatedFutureContingentConsiderationPaymentsYearTwo
2364000
CY2021Q2 rcmt Excess Of Current Assets Over Current Liabilities
ExcessOfCurrentAssetsOverCurrentLiabilities
26100000
CY2021Q1 rcmt Future Grants Of Options Or Shares
FutureGrantsOfOptionsOrShares
520929
CY2021Q2 rcmt Imputed Interest On Contingent Consideration
ImputedInterestOnContingentConsideration
26000
CY2020Q1 rcmt Imputed Interest On Contingent Consideration
ImputedInterestOnContingentConsideration
36000
CY2021Q2 rcmt Increase Decrease In Finance Lease Liability
IncreaseDecreaseInFinanceLeaseLiability
-71000
CY2020Q1 rcmt Increase Decrease In Finance Lease Liability
IncreaseDecreaseInFinanceLeaseLiability
-80000
CY2021Q2 rcmt Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
-146000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10237000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
362000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
69000
CY2020Q1 rcmt Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
-304000
CY2021Q2 rcmt Increase Decrease In Right Of Use Liabilities
IncreaseDecreaseInRightOfUseLiabilities
366000
CY2020Q1 rcmt Increase Decrease In Right Of Use Liabilities
IncreaseDecreaseInRightOfUseLiabilities
284000
CY2021Q2 rcmt Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
4354000
CY2020Q2 rcmt Minimum Percent Of Common Stock To Be Purchased For Rights To Become Exercisable
MinimumPercentOfCommonStockToBePurchasedForRightsToBecomeExercisable
0.1
CY2021Q2 rcmt Proceeds From Stock Subscription
ProceedsFromStockSubscription
97000
CY2020Q1 rcmt Proceeds From Stock Subscription
ProceedsFromStockSubscription
CY2021Q2 rcmt Stock Subscribed During Period Value New Issues
StockSubscribedDuringPeriodValueNewIssues
97000
CY2021Q2 rcmt Transit Accounts Payable
TransitAccountsPayable
4551000
CY2021Q1 rcmt Transit Accounts Payable
TransitAccountsPayable
4900000
CY2021Q2 rcmt Write Off Of Fully Depreciated Property And Equipment
WriteOffOfFullyDepreciatedPropertyAndEquipment
451000
CY2020Q1 rcmt Write Off Of Fully Depreciated Property And Equipment
WriteOffOfFullyDepreciatedPropertyAndEquipment
960000
CY2020Q1 rcmt Writeoff Of Receivables Related To Arbitration
WriteoffOfReceivablesRelatedToArbitration
8047000
CY2021Q2 rcmt Writeoff Of Receivables Related To Arbitration
WriteoffOfReceivablesRelatedToArbitration
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7326000
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7895000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45282000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36007000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-56000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1205000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2922000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3107000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2661000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2550000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110179000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
109588000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
545000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
69000
CY2021Q2 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-10197000
CY2020Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
6874000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
362000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
69000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1418000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1750000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021Q2 us-gaap Assets
Assets
77770000
CY2020Q1 us-gaap Assets
Assets
83951000
CY2021Q1 us-gaap Assets
Assets
68339000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
54108000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
43934000
CY2021Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
26000
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
36000
CY2021Q2 us-gaap Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
3100000
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
520000
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
500000
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
2364000
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
2358000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
678000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
734000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
734000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1847000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
678000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
642000
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1094026
CY2021Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1380628
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2021Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
323000
CY2021Q1 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
420000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16510793
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16224191
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11485310
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11542880
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12894000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12877000
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
826000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
811000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
896000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6076000
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33699000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34190000
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3002000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3300000
CY2021Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
169000
CY2021Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
169000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
346000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
335000
CY2021Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
266000
CY2020Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
255000
CY2021Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-134000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-165000
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.274
CY2021Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000
CY2020Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000
CY2021Q2 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1000
CY2020Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
2000
CY2021Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
279000
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
353000
CY2021Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
183000
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
247000
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
96000
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
106000
CY2021Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
288000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
108000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
CY2021Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
180000
CY2021Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
9000
CY2021Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
74000
CY2020Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
80000
CY2021Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1140000
CY2021Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1140000
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
91000
CY2020Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
78000
CY2021Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0288
CY2021Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0263
CY2021Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y156D
CY2021Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y164D
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
135000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-33000
CY2021Q2 us-gaap Goodwill
Goodwill
16354000
CY2021Q1 us-gaap Goodwill
Goodwill
16354000
CY2021Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q2 us-gaap Gross Profit
GrossProfit
10850000
CY2020Q1 us-gaap Gross Profit
GrossProfit
10843000
CY2021Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1363000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8185000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
356000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2240000
CY2021Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
236000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
43000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-588000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6000
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9085000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-974000
CY2021Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-157000
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
21000
CY2021Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-302000
CY2020Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
2217000
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
187000
CY2020Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1289000
CY2021Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1802000
CY2020Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-973000
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-582000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-166000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
389857
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
95000
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-121000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-340000
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
254000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
420000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1532000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
48000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
233000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
967000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1574000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
193000
CY2021Q2 us-gaap Liabilities
Liabilities
54844000
CY2021Q1 us-gaap Liabilities
Liabilities
46101000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77770000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68339000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
27762000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
28741000
CY2021Q2 us-gaap Litigation Reserve
LitigationReserve
1800000
CY2021Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
22029000
CY2021Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
11890000
CY2021Q2 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 18pt;">&nbsp;</td> <td style="width: 18pt;"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">16.</div></div></div> </td> <td> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;">Contingencies</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the ordinary business course.&nbsp; These matters <div style="display: inline; font-style: italic; font: inherit;"> may </div>relate to professional liability, tax, compensation, contract, competitor disputes, and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company's employment and compensation practices. Additionally, some of the Company's clients <div style="display: inline; font-style: italic; font: inherit;"> may </div>also become subject to claims, governmental inquiries and investigations, and legal actions relating to the Company's professional services. Depending upon the particular facts and circumstances, the Company <div style="display: inline; font-style: italic; font: inherit;"> may </div>also be subject to indemnification obligations under its contracts with such clients relating to these matters.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">As such, the Company is required to assess the likelihood of any adverse outcomes to these matters as well as potential ranges of losses and possible recoveries.&nbsp; The Company <div style="display: inline; font-style: italic; font: inherit;"> may </div><div style="display: inline; font-style: italic; font: inherit;">not</div> be covered by insurance as it pertains to some or all of these matters.&nbsp; A determination of the amount of the provision required for these commitments and contingencies, if any, which would be charged to earnings, is made after careful analysis of each matter.&nbsp; The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. Once established, a provision <div style="display: inline; font-style: italic; font: inherit;"> may </div>change in the future due to new developments or changes in circumstances and could increase or decrease the Company's earnings in the period that the changes are made.&nbsp;</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">The Company is exposed to various asserted claims as of <div style="display: inline; font-style: italic; font: inherit;"> April 3, 2021, </div>where the Company believes it has a probability of loss. As of <div style="display: inline; font-style: italic; font: inherit;"> April 3, 2021, </div>the Company has accrued <div style="display: inline; font-style: italic; font: inherit;">$1.8</div> million for asserted claims of <div style="display: inline; font-style: italic; font: inherit;">$2.0</div> million.&nbsp; Additionally, the Company is exposed to other asserted claims whereby an amount of loss has <div style="display: inline; font-style: italic; font: inherit;">not</div> been declared, and the Company can't determine the potential loss. Any of these various claims could result in an unfavorable outcome or settlement that exceeds the accrued amounts. However, the Company believes that such matters will <div style="display: inline; font-style: italic; font: inherit;">not,</div> either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations, or cash flows. Included in the <div style="display: inline; font-style: italic; font: inherit;"> April 3. 2021 </div>accrual of <div style="display: inline; font-style: italic; font: inherit;">$1.8</div> million, the Company has reserved <div style="display: inline; font-style: italic; font: inherit;">$1.7</div> million for the settlement of a class-action suit in California that alleges the Company did <div style="display: inline; font-style: italic; font: inherit;">not</div> properly pay its travel nurses overtime wages. While the Company believes it did <div style="display: inline; font-style: italic; font: inherit;">not</div> violate any overtime wage laws, it nevertheless decided to settle this class action lawsuit in <div style="display: inline; font-style: italic; font: inherit;"> December 2020.&nbsp; </div>The Company expects to pay the <div style="display: inline; font-style: italic; font: inherit;">$1.7</div> million settlement sometime during the <div style="display: inline; font-style: italic; font: inherit;">third</div> quarter of fiscal <div style="display: inline; font-style: italic; font: inherit;">2021.</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></div></div>
CY2021Q2 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
2000000
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9315000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1934000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9190000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
929000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1007000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5945000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
9475000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
18619000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1375000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7776000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
537000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
656000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4161000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4527000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1937000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1886000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2224000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2641000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
552000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
663000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2263000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2409000
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0308
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0406
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y131D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10D
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-111000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-131000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-409000
CY2021Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3947000
CY2021Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2494000
CY2021Q2 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2020Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2021Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
911000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
95988
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4201000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4699000
CY2021Q2 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
26186000
CY2020Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
22279000
CY2021Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
60000
CY2020Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
140000
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
60000
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4781000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5185000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1859000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2078000
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-150000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7792000
CY2021Q2 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
16046000
CY2020Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
24273000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66967000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67974000
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
44549000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
45033000
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
145000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
250000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9069000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
149894
CY2021Q2 us-gaap Share Price
SharePrice
3.75
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
61000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
140000
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
CY2021Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
6600000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
22926000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
22238000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
32403000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
26536000
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
351000
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
436000
CY2021Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
2.65
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5025483
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
4681311
CY2021Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
344172
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
18128000
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
17217000
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
911000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11929246
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13111550
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11539389
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13111550

Files In Submission

Name View Source Status
0000700841-21-000024-index-headers.html Edgar Link pending
0000700841-21-000024-index.html Edgar Link pending
0000700841-21-000024.txt Edgar Link pending
0000700841-21-000024-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q040321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
rcmt-20210403.xml Edgar Link completed
rcmt-20210403.xsd Edgar Link pending
rcmt-20210403_cal.xml Edgar Link unprocessable
rcmt-20210403_def.xml Edgar Link unprocessable
rcmt-20210403_lab.xml Edgar Link unprocessable
rcmt-20210403_pre.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending